Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 16 January 2025
      Patient-centered innovation: Can Europe lead the way?
 
 
An op-ed by Dr Paola Casarosa, member of the board of managing directors at Boehringer...
 

We can’t make true progress on unmet medical needs unless we understand what the patients themselves think they need or say is missing from their treatment options.

Since a young age growing up in Italy, the workings of the human body have fascinated me — a curiosity that brought me to medical research. I’ve always wanted to help people. And through discovering new medicines, we can potentially help millions of patients.

What drives me — and so many other scientists in Europe and around the globe — is a desire to find new therapies that will improve people’s lives, especially in areas where there is currently an unmet need.

 

Read more →
 
 
      IMAGINE if Europe was a leader in life sciences

Europe has great potential, a highly skilled workforce, cutting-edge science and world-renowned academic institutions. However, in recent years, investment has grown faster in other parts of the world. 

To restore Europe’s position as a leader in life sciences, President von der Leyen has called for a Strategy for European Life Sciences.

Europe has the potential. And now the ambition. It is time to act.

Watch the full video here.

 
 
      IHI launches Call 10

Today, IHI launches Call 10, committing €48 million to tackle PFAS in the health sector through:

  • Mapping PFAS usage across the sector.
  • Driving initiatives to reduce reliance on PFAS.
  • Identifying safer alternatives to protect both health and the environment.
EFPIA and MedTech members will provide in-kind contributions covering half of this investment. Together, we’re paving the way toward a healthier, more sustainable future.

Learn how to get involved: IHI Call 10.

 
 
 
      Events
 
 
28 JAN 2025
  5th Nordic RWE and AI conference Helsinki, Finland

How will broad use of RWD and AI change Drug discovery and development and will the use of data improve the competitiveness...

Learn more →
 
 
 
19 MAR 2025
  Cancer Care 2030: From policy ambition to impact Brussels, Belgium

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care

Learn more →
 
 
      Rethinking Alzheimer’s Disease Pathway: From Diagnosis to Care
In December, the European Parliament hosted an event gathering policymakers, patients, scientists, and industry representatives to launch "Rethinking Alzheimer’s Disease Pathway: From Diagnosis to Care."

Described by MEP Tsvetelina Penkova, the event’s host, as “not just a document, but a roadmap” offering “the real solutions we need to implement,” this initiative marks a new step toward patient-centred care.

Discover the key takeaways from the report here.
 
 
      What we are reading
Human Medicines in 2024 16 January 2025  (EMA) Read more →
Inclusion in neurological research: empowering people living with neurological diseases 07 January 2025  (NIH) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe